mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
7e-05 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0007 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0009 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.001 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.004 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.004 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.005 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.006 |